Han B - Search Results

1

Rituximab Plus Bortezomib for Relapsed and Refractory Warm Autoimmune Hemolytic Anemia: A Prospective Phase 2 Trial.

Lin X, Yang C, Zhuang J, Li J, Zhou D, Chen M, Han B. Lin X, et al. Among authors: han b. Am J Hematol. 2025 Feb;100(2):326-329. doi: 10.1002/ajh.27540. Epub 2024 Dec 21. Am J Hematol. 2025. PMID: 39708374 No abstract available.

2

Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.

Huang Y, Chen M, Yang C, Ruan J, Wang S, Han B. Huang Y, et al. Among authors: han b. Leukemia. 2022 May;36(5):1351-1360. doi: 10.1038/s41375-022-01532-1. Epub 2022 Mar 7. Leukemia. 2022. PMID: 35256763

3

Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study.

Chi Y, Hu Q, Yang C, Chen M, Han B. Chi Y, et al. Among authors: han b. Exp Hematol. 2023 Jan;117:62-68. doi: 10.1016/j.exphem.2022.11.002. Epub 2022 Nov 16. Exp Hematol. 2023. PMID: 36400314 Free article.

4

Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial.

Wan Z, Chen M, Han B. Wan Z, et al. Among authors: han b. Ann Med. 2023 Dec;55(1):2224044. doi: 10.1080/07853890.2023.2224044. Ann Med. 2023. PMID: 37318085 Free PMC article. Clinical Trial.

5

Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study.

Zhang Z, Hu Q, Tang X, Zhang M, Jia J, Shi H, Ding X, Yang C, Chen M, Han B. Zhang Z, et al. Among authors: han b. Ann Hematol. 2023 Nov;102(11):3039-3047. doi: 10.1007/s00277-023-05334-y. Epub 2023 Sep 8. Ann Hematol. 2023. PMID: 37682325

6

Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China.

Zhang Z, Hu Q, Yang C, Chen M, Han B. Zhang Z, et al. Among authors: han b. Ther Adv Hematol. 2023 Sep 14;14:20406207231191310. doi: 10.1177/20406207231191310. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37719987 Free PMC article.

7

Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial.

Ji J, Wan Z, Ruan J, Yang Y, Hu Q, Chen Z, Yang C, Chen M, Han B. Ji J, et al. Among authors: han b. Blood Cancer J. 2023 Sep 19;13(1):146. doi: 10.1038/s41408-023-00921-8. Blood Cancer J. 2023. PMID: 37726286 Free PMC article. Clinical Trial.

8

Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study.

Zhang Z, Hu Q, Yang C, Chen M, Han B. Zhang Z, et al. Among authors: han b. Ann Med. 2023;55(2):2282180. doi: 10.1080/07853890.2023.2282180. Epub 2023 Nov 15. Ann Med. 2023. PMID: 37967535 Free PMC article.

9

High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study.

Yang Y, Hu Q, Yang C, Chen M, Han B. Yang Y, et al. Among authors: han b. Hematology. 2024 Dec;29(1):2298523. doi: 10.1080/16078454.2023.2298523. Epub 2023 Dec 29. Hematology. 2024. PMID: 38156735 Free article.

10

Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone.

Lan X, Zhang F, Yang C, Su W, Du J, Liu S, Chen M, Han B, Zhou D, Zhuang J. Lan X, et al. Among authors: han b. Chronic Dis Transl Med. 2023 Oct 31;10(1):62-68. doi: 10.1002/cdt3.99. eCollection 2024 Mar. Chronic Dis Transl Med. 2023. PMID: 38450304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,984 results

Search Page

Filters